DiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
DiaMedica Announces Poster Presentation at International Stroke Conference
DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer
DiaMedica Therapeutics Announces Third Quarter 2023 Financial Results
DiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023
DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results
DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer
DiaMedica Therapeutics to Participate at Lake Street’s 7th Annual Best Ideas Growth Conference
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results